Quantum Biopharma share price logo

Quantum Biopharma

NASDAQ: QNTM

$3.70

+0.09

(+2.49%)

as on

Quantum Biopharma Stock Performance

as on September 23, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.63
    $3.88
    downward going graph

    1.89%

    Downside

    4.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.07
    $19.42
    downward going graph

    44.05%

    Downside

    424.91%

    Upside

    downward going graph

Quantum Biopharma share price movements today

Previous Close
$3.61
Open
$3.63
Volume
1.3M
Market Cap
$23.5M
Day's Low - High
$3.63 - $3.88
52 Week Low - High
$2.07 - $19.42

Quantum Biopharma Historical Returns

1 Month Return
+ 4.94 %
3 Month Return
-1.37 %
1 Year Return
-80.48 %
3 Year Return
0 %
5 Year Return
0 %

Quantum Biopharma Stock Fundamentals & Key Indicators

Check Quantum Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.5M

EPS (TTM)

-5.65

Dividend Yield

0.00%

PE Ratio (TTM)

-0.65

Industry PE ratio

-2.33

PEG Ratio

-0.004180346630499614

Return On Equity TTM

-413.07%

Quantum Biopharma Stock Valuation

Track how Quantum Biopharma P/E has moved over time to understand its valuation trends.

Quantum Biopharma in the last 5 years

  • Overview

  • Trends

Lowest (-2.03x)

December 31, 2023

Industry (-2.33x)

December 31, 2025

Today (-0.90x)

December 31, 2025

Highest (-0.29x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.90x

Quantum Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quantum Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$23.5MNA-0.650.00%0.00%
Neutral$61.5B-60.76%-19.3-12.57%0.00%
StrongBuy$128.8B177.16%29.3586.04%0.00%
Buy$80.8B23.35%18.4884.86%0.47%

Stock Returns calculator for Quantum Biopharma Stock including INR - Dollar returns

The Quantum Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Quantum Biopharma investment value today

Current value as on today

₹21,660

Returns

-₹78,340

(-78.34%)

Returns from Quantum Biopharma Stock

-₹79,989 (-79.99%)

Dollar Impact

₹1,649 (+1.65%)

Analyst Recommendation on Quantum Biopharma Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Quantum Biopharma. Average target price of $8

Indian Investors' Interest in Quantum Biopharma Stock

Search interest for Quantum Biopharma Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

Quantum Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
0
Operating Income
-2
-3
-4
-6
-3
-4
-4
7
-2
-2
EBITDA
-1
-3
-3
-5
-8
-9
-4
-3
-13
-2
Interest Expense
0
0
0
0
0
0
0
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-3
-4
-5
-8
-9
-4
-3
-13
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-3
-3
-5
-8
-9
-5
-3
-13
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quantum Biopharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
-
-
-
-
-
-
-
Gross Profit
0
0
-2
-
-
-
-
-
-
Operating Income
-2
-
-30
-30
-33
-27
-23
-16
-15
EBITDA
-2
-16
-31
-24
-29
-22
-15
-14
-25
Interest Expense
-
-
0
0
0
0
0
0
0
Depreciation
-
0
1
3
4
4
2
0
0
Income Before Tax
-2
-16
-46
-28
-33
-26
-18
-14
-26
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-2
-22
-39
-31
-35
-23
-17
-14
-26
Net Profit Margin
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quantum Biopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-3
-4
-5
-8
-9
-4
-3
-13
-3
Operating Cash Flow
-1
0
-3
0
-4
-1
-1
0
-1
-1
Investing Cash Flow
0
0
-3
1
-1
-1
0
0
-2
-1
Financing Cash Flow
0
1
6
2
3
1
0
1
6
2
Change in Cash
-1
1
0
2
-2
-2
-1
1
2
0

Quantum Biopharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-16
-34
-28
-33
-26
-18
-14
-26
Operating Cash Flow
0
-13
-13
-19
-20
-28
-10
-6
-8
Investing Cash Flow
-6
-7
0
6
0
12
0
-1
-1
Financing Cash Flow
9
32
4
24
38
-2
-3
11
6
Change in Cash
3
12
-9
11
17
-18
-14
3
-4

Global Institutional Holdings in Quantum Biopharma

Funds
Holdings
AdvisorShares
4.95%

Quantum Biopharma News & Key Events

  • img

    Today's Timeline - 15 September

    Tue, 05:30 PM

    -

    FDA approves Quantum BioPharma's Lucid-MS for Phase 2 trials in progressive MS patients.

Insights on Quantum Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, QNTM stock has moved up by 61.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 551.1% return, outperforming this stock by 631.6%

About Quantum Biopharma

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
OrganisationQuantum Biopharma
Headquarters55 University Ave., Toronto, ON, M5J 2H7, CA
IndustryDrug Manufacturers - Specialty & Generic
CEOZeeshan Saeed
E-voting on sharesClick here to vote

Key Management of Quantum Biopharma

Name

Title

Ms. Maryann Adesso

Corporate Secretary

Randell Mack

President of FSD BioSciences

Mr. Kevin Cassidy

Vice President of Quality-Lucid

Mr. Zeeshan Saeed

Co-Founder, CEO & Executive Non-Independent Co-Chairman

Mr. Anthony John Durkacz

Co-Founder & Executive Non-Independent Co-Chairman

Mr. Donal Carroll C.M.A., CPA

Chief Financial Officer

Mr. Jason David Sawyer

Head of Finance & Mergers and Acquisitions

Dr. Ashwini Joshi M.S.

Director of Pharmaceutical Development

Dr. Patrick Onyango Ph.D.

Director of Operations at U.S.

FAQs

What is Quantum Biopharma share price today?

Quantum Biopharma share price today is $3.70 as on at the close of the market. Quantum Biopharma share today touched a day high of $3.88 and a low of $3.63.

What is the 52 week high and 52 week low for Quantum Biopharma share?

Quantum Biopharma share touched a 52 week high of $19.42 on and a 52 week low of $2.07 on . Quantum Biopharma stock price today i.e. is closed at $3.70,which is 80.95% down from its 52 week high and 78.74% up from its 52 week low.

What is Quantum Biopharma's market capitalisation today?

Quantum Biopharma market capitalisation is $0.00T as on .

How to invest in Quantum Biopharma Stock (QNTM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Quantum Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quantum Biopharma Shares that will get you 0.4054 shares as per Quantum Biopharma share price of $3.70 per share as on September 23, 2026 at 1:29 am IST.

What is the minimum amount required to buy Quantum Biopharma Stock (QNTM) from India?

Indian investors can start investing in Quantum Biopharma (QNTM) shares with as little as ₹95.58 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.80 in Quantum Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Quantum Biopharma share’s latest price of $3.70 as on September 23, 2026 at 1:29 am IST, you will get 2.7027 shares of Quantum Biopharma. Learn more about fractional shares .